Drug Name:
AZASITE Rx
Generic Name and Formulations:
Azithromycin 1%; oph. soln; contains benzalkonium chloride.
Company:
Akorn, Inc.
Therapeutic Use:
Indications for AZASITE:
Susceptible bacterial conjunctivitis.
Adults and Children:
<1yr: not recommended. ≥1yr: 1 drop in affected eye(s) twice daily (8–12hrs apart) for 2 days then once daily for the next 5 days.
Warnings/Precautions:
Remove contact lenses during therapy. Pregnancy (Cat.B). Nursing mothers.
Pharmacological Class:
Macrolide.
Adverse Reactions:
Eye irritation, superinfection; rare: contact dermatitis, corneal erosion, dysgeusia, dry eye, punctate keratitis, others.
How Supplied:
Soln—2.5mL
Clinical Pain Advisor Articles
- Abuse-Deterrent Opioid Formulations: Barriers to Broader Use
- Notifications by PDMPs May Not Effectively Reduce Opioid Misuse
- Virtual Reality May Effectively Reduce Sensory, Affective, and Cognitive Pain During Labor
- Electroacupuncture May Help Reduce Opioid Use in Chronic Musculoskeletal Pain
- Medical Cannabis Legalization Associated With Reduced Schedule III Opioid Prescriptions
- Neuropathic Pain Medications
- Higher Buprenorphine Dose May Not Increase Severity of Neonatal Abstinence Syndrome
- Terms Used for Addiction May Be Associated With Explicit, Implicit Bias
- Ketamine Infusions May Be Effective for Refractory Headache
- Physical, Psychosocial Activity May Be Protective Against Development of Chronic Pain in Older Adults
- Predicting Pain Chronicization After Spine Surgery
- Chronic Low Back Pain Levels Vary Between Sex and Race
- FDA Approval of Medication With a Digital Monitoring System: Major Breakthrough or "Brave New World"?
- Errors in Clinical Notes Generated by Speech Recognition Are Not Uncommon
- Reducing Mortality After Overdose: Is Treatment for Opioid Use Disorder Effective?
